Amneal Pharmaceuticals, Inc. Class A Common Stock Cash Flow Quality Index
Amneal Pharmaceuticals, Inc. Class A Common Stock cash flow quality index. Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) has a Cash Flow Quality Index of 8.15x as of September 2026. Operating cash flow of $100.28 Million exceeds net income of $12.31 Million, indicating high earnings quality where cash backs reported profits. See Amneal Pharmaceuticals, Inc. Class A Com financial flexibility index to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Amneal Pharmaceuticals, Inc. Class A Common Stock (2014–2025)
Cash flow quality index of Amneal Pharmaceuticals, Inc. Class A Common Stock from 2014 to 2025. Historical Cash Flow Quality Index for Amneal Pharmaceuticals, Inc. Class A Common Stock across 7 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore AMRX operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
Amneal Pharmaceuticals, Inc. Class A Common Stock Cash Flow Quality Index by Year (2014–2025)
Amneal Pharmaceuticals, Inc. Class A Common Stock cash flow quality index by year from 2014 to 2025. Year-by-year earnings quality comparison for Amneal Pharmaceuticals, Inc. Class A Common Stock. For the full cash flow conversion analysis, see AMRX cash generation efficiency.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 4.72x | $339.99 Million | $72.06 Million | ▼ -79.3% |
| 2021 | 22.76x | $241.82 Million | $10.62 Million | ▲ +446.9% |
| 2020 | 4.16x | $379.00 Million | $91.06 Million | ▲ +200.9% |
| 2017 | 1.38x | $234.19 Million | $169.32 Million | ▲ +151.7% |
| 2016 | 0.55x | $115.06 Million | $209.43 Million | ▼ -11.2% |
| 2015 | 0.62x | $104.88 Million | $169.45 Million | ▼ -2.4% |
| 2014 | 0.63x | $112.26 Million | $176.93 Million | — |